For Women With Early Breast Cancer, Herceptin Treatment Can Be Much Shorter

A large, new study shows that the treatment regimen, typically recommended for a year, can be just as effective at 6 months, reducing serious side effects and costs.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News